Project Details
Description
Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia- COST
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/21 → 2/29/24 |
Funding
- CLEVELAND CLINIC
- NIH NATL HEART, LUNG AND BLOOD INSTITU
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.